Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1BIOGEN CANADA INC

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

NATALIZUMAB

Brand Name : TYSABRI

Dosage Form : SOLUTION

Dosage Strength : 300MG/15ML

Packaging : 1VIAL

Approval Date :

Application Number : 2286386

Regulatory Info : Prescription

Registration Country : Canada

blank